Description
DOPAZIN-V — Dapagliflozin and Vildagliptin Combined for Sharper Glycemic Control
DOPAZIN-V is a sustained-release formulation of Dapagliflozin 10 mg and Vildagliptin 100 mg, developed for the management of Type 2 Diabetes Mellitus. Dapagliflozin acts as a potent, selective SGLT2 inhibitor that lowers serum glucose by reducing renal glucose reabsorption in an insulin-independent manner, while Vildagliptin enhances pancreatic islet cell responsiveness to glucose and is recognised for suppressing glucagon more effectively than several other DPP-4 inhibitors, resulting in less glycemic variation. This combination gives physicians a dual-pathway option for patients who need tighter glucose control, positioning DOPAZIN-V as a meaningful new-launch addition to any diabetology basket.
Manufacturing Discipline Behind Every Batch
Lxir Medilabs is an ISO and WHO-GMP certified pharmaceutical company headquartered in Panchkula, Haryana with manufacturing carried out at our Baddi, Himachal Pradesh facility. As a sustained-release combination, DOPAZIN-V demands precise formulation control to maintain its release profile batch after batch and that consistency is built into our manufacturing process. For a PCD pharma franchise company in India, offering a new-launch molecule with this level of quality assurance helps partners approach diabetologists and physicians with genuine confidence.
Product Highlights for Franchise Partners
- Composition: Dapagliflozin 10 mg + Vildagliptin 100 mg (Sustained Release Tablets)
- Pack Size: 10 x 10 Tablets
- Indication: Diabetes Mellitus Type-2
- Key Benefit: Dual-pathway glycemic control with reduced glucagon variability
- Category Status: New product launch for early market entry
- Suited For: Distributors and medical representatives expanding their diabetology line
Franchise partners looking to introduce a differentiated diabetes combination can explore this and other formulations through our PCD pharma franchise division, with complete launch and promotional support.
Disclaimer: This is a prescription product and should be used strictly under the supervision of a registered medical practitioner.
